Rx-360 summary of WHO supplementary guidelines on GMP for HVAC systems for non-sterile pharmaceuticals
These guidelines primarily focus on recommendations for systems for manufactures of solid dosage forms.
WHO has issued a revision to their supplementary guidelines on GMP for HVAC systems for non-sterile pharma dosage forms. This draft was necessitated because of the new, current trends in engineering and the experience gained during the implementation of this guidance in inspections.
This update also includes improved graphic images to make them more readable. These guidelines primarily focus on recommendations for systems for manufactures of solid dosage forms. The guidelines also refer to other systems or components which are not relevant to solid dosage for manufacturing plants, but which may assist in providing a comparison between the requirements for solid dosage-form plants and other systems.
This document provides guidance to pharmaceutical manufacturers and inspectors of pharmaceutical manufacturing facilities on the design, installation, qualification and maintenance of the HVAC systems. These guidelines are intended to complement those provided in "Good manufacturing practices for pharmaceutical products" and should be read in conjunction with the parent guide. The additional standards addressed by the present guidelines should, therefore, be considered supplementary to the general requirements set out in the parent guide. In addition, these guidelines are not intended to be prescriptive in specifying requirements and design parameters.
These guidelines focus primarily on the design and good manufacturing practices (GMP) requirements for HVAC systems for facilities for the manufacture of solid dosage forms. Most of the system design principles for facilities manufacturing solid dosage forms also apply to facilities manufacturing other dosage forms and other classes of products including biological products, herbal medicines, complimentary medicines and finishing process steps for APIs. Additional specific requirements apply for handling of sterile products and hazardous products. Guidelines for hazardous, sterile and biological product facilities are covered in separate WHO guidelines.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance